Cargando…
Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects
Medically refractory epilepsy remains an area of intense clinical and scientific interest since a significant porportion of patients continue to suffer from debilitating seizures despite available therapies. In this setting, recent studies have focused on assessing the benefits of cannabidiol (CBD)-...
Autores principales: | Sekar, Krithiga, Pack, Alison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396837/ https://www.ncbi.nlm.nih.gov/pubmed/30854190 http://dx.doi.org/10.12688/f1000research.16515.1 |
Ejemplares similares
-
Zonisamide Efficacy as Adjunctive Therapy in Children With Refractory Epilepsy
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2013) -
Clinical Trial of Vigabatrin as Adjunctive Therapy in Children with Refractory Epilepsy
por: Taghdiri, Mohammad-Mahdi, et al.
Publicado: (2013) -
Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
por: de MANREZA, Maria Luiza Giraldes, et al.
Publicado: (2021) -
A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer
por: Myint, Zin W., et al.
Publicado: (2023) -
Adverse Events During Perampanel Adjunctive Therapy in Intractable Epilepsy
por: Youn, Song Ee, et al.
Publicado: (2018)